IgE-Mediated allergy to pyrazolones, quinolones and other non-β-Lactam antibiotics

Drug Hypersensitivity

Volumn , Issue , 2007, Pages 216-232

  Campi Dr , Paolo ^a   Severino, Maurizio ^a   Manfredi, Mariangela ^a  

^a SANTA MARIA ANNUNZIATA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84882119070     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1159/000104202     Document Type: Chapter

References (41)

1. Arndt KA, Jick H: Rates of cutaneous reactions to drugs. A report from the Boston Collaborative Drug Surveillance Program. JAMA 1976; 235: 918-922.
2. Caldwell JR, Cluff LE: Adverse reactions to antimicrobial agents. JAMA 1974; 230: 77-80.
3. Naldi L, Conforti A, Venegoni M, Troncon MG, Caputi A, Ghiotto E, et al: Cutaneous reactions to drugs. An analysis of spontaneous reports in four Italian regions. J Clin Pharmacol 1999; 48: 839-846.
4. Harle DG, Baldo BA, Smal MA, Van Nunen SA: An immunoassay for the detection of IgE antibodies to trimethoprim in the sera of allergic patients. Clin Allergy 1987; 17: 209-216.
5. Baldo BA, Harle DG: Drug allergenic determinants. Monogr Allergy 1990; 28: 11-51.
6. Campi P, Manfredi M, Severino MG, Zerboni R: IgE specifiche verso chinoloni. G Ital Allergol Immunol Clin 2000; 11: 63-67.
7. Campi P, Pichler WJ: Quinolone hypersensitivity. Curr Opin Allergy Clin Immunol 2003; 3: 275-281.
8. Manfredi M, Severino M, Testi S, Macchia D, Ermini G, Pichler WJ, Campi P: Detection of specific IgE to quinolones. J Allergy Clin Immunol 2004; 113: 155-160.
9. Pascual C, Crespo JF, Quiralte J, Lopez C, Wheeler G, Martin-Esteban M: In vitro detection of specific IgE antibodies to erythromycin. J Allergy Clin Immunol 1995; 95: 668-671.
10. Burke P, Burne SR: Allergy associated with ciprofloxacin. BMJ 2000; 320: 679.
11. Davis H, McGoodwin E, Greene Reed T: Anaphylactoid reactions reported after treatment with ciprofloxacin. Ann Intern Med 1989; 111: 1041-2043.
12. Scherer K, Bircher AJ: Hypersensitivity reactions to fluoroquinolones. Curr Allergy Asthma Rep 2005; 5: 15-21.
13. Empedrad R, Carter AL, Earl HS, Gruchalla RS: Nonirritating intradermal skin test concentrations for commonly prescribed antibiotics. J Allergy Clin Immunol 2003; 112: 629-630.
14. Davila I, Diez ML, Quirce S, Fraj J, De La Hoz B, Lazaro M: Cross-reactivity between quinolones -report of three cases. Allergy 1993; 48: 388-390.
15. Colàs C, Pola J, Zapata C, Dominguez A, Gimeno A, Duce F: Quinolone hypersensitivity: clinical and immunological aspects (abstract). J Allergy Clin Immunol 1993; 91: 365.
16. Valdivieso R, Pola J, Losada E, Subiza J, Armentia A, Zapata C: Severe anaphylactoid reaction to nalidixic acid. Allergy 1988; 43: 71-73.
17. The Merck Index. Whitehouse Station, Merck Research Laboratories, 1996.
18. Apolant H: Die Antipyrinexantheme. Arch Derm Syph 1898; 46: 345-398.
19. Halpern B, Holtzer A, Liacopoulust P,Meyer J: Allergy to pyrazolone derivates (aminopyrine) with evidence of reaginic type antibody. J Allergy 1958; 29: 1-12.
20. Wüthrich B, Fabro L, Wälti M: Soforttyp-Reaktionen auf Pyrazolderivate: Ergebnisse von Hauttesten und Antikörperbestimmungen. Dermatologica 1986; 173: 24-28.
21. Mandallaz M, de Weck AL, Frosch P, Haustein U, Maucher OM, Patriarca G, et al: A prospective survey of allergy/ intolerance to pyrazolones, salicylates and betalactams and skin-testing with polylysine conjugates. Int Arch Allergy Appl Immunol 1987; 83:S1.
22. Girard JP, Zawodnik S: Diagnostic procedures in drug allergy; in de Weck AL, Bundgaard H (eds): Allergic Reactions to Drugs. Berlin, Springer, 1983, pp 207-225.
23. Wälti M, Neftel KA, Cohen M, Winkler P, de Weck AL: Radioimmunologische Erfassung von IgE-und IgG-Antikörpern gegen Medikamente. Schweiz Med Wochenschr 1986; 116: 303-305.
24. Zhu D, Becker WM, Schulz KH, Schubeler K, Schlaak M: Detection of IgE antibodies specific for 1-phenyl-2,3-dimethyl-3-pyrazoline-5-one by RAST: a serological diagnostic method for sensitivity to pyrazoline drugs. Asian Pacific J Allergy Immunol 1992; 10: 95-101.
25. Kowalski ML, Bienkiewicz B, Woszczek G, Iwaszkiewicz J, Poniatowska M: Diagnosis of pyrazolone drug sensitivity: clinical history versus skin testing and in vitro testing. Allergy Asthma Proc 1999; 20: 347-352.
26. Rubio M, Herrero MT, de Barrio M, Tornero P, Rodriguez V, Aranzàbal A, et al: Alergia a pirazolonas. Allergol Immunopathol 1994; 22: 104-106.
27. Himly M, Jahn-Schmid B, Pittertschatscher K, Bohle B, Grubmayr K, Ferreira F, et al: IgE-mediated immediate-type hypersensitivity to the pyrazolone drug propyphenazone. J Allergy Clin Immunol 2003; 111: 882-888.
28. Zhu D, Becker WM, Schulz KH, Schubeler K, Schlaak M: The presence of specific IgE to salicyloyl and o-methylsalicyloyl in aspirin-sensitive patients. Asian Pacific J Allergy Immunol 1992; 10: 25-32.
29. Sanz ML, Garcìa MC, Caballero MR, Diéguez I, Gamboa PM: Test de activaciòn de basòfilos en el diagnòstico de alergia a medicamentos. An Sis Sanit Navar 2003; 26(suppl 2):39-47.
30. Przybilla B, Ring J, Harle R, Galosi A: Oraler Expositionstest mit Schmerzmittel-Inhaltsstoffen bei Patienten mit anaphylaktoiden Unverträglichkeitsreaktionen auf 'leichte' Analgetika. Allergologie 1986; 9: 315-318.
31. Czerniawska-Mysik G, Szczeklik A: Idiosyncrasy to pyrazolone drugs. Allergy 1981; 36: 381-384.
32. Kowalski ML, Woszczek G, Bienkiewicz B, Mis M: Association of pyrazolone drug hypersensitivity with HLADQ and DR antigens. Clin Exp Allergy 1998; 28: 1153-1158.
33. Demoly P, Kropf R, Bircher A, Pichler W: Drug hypersensitivity questionnaire. Allergy 1999; 54: 999-1003.
34. Messaad D, Sahla H, Benahmed S, Godard P, Bousquet J, Demoly P: Drug provocation tests in patients with a history suggesting an immediate drug hypersensitivity reaction. Ann Intern Med 2004; 140: 1001-1006.
35. Benahmed S, Scaramuzza C, Messaad D, Sahla H, Demoly P: The accuracy of the diagnosis of suspected macrolide antibiotic hypersensitivity: results of a single-blinded trial. Allergy 2004; 59: 1130-1133.
36. Ponvert C, Scheinmann P: Antibiotic allergy and pseudo-allergy in child. Rev Fr Allergol Immunol Clin 2003; 43: 385-392.
37. Brockow K, Romano A, Blanca M, Ring J, Pichler W, Demoly P, et al; ENDA (European Network for Drug Allergy): General considerations for skin test procedures in the diagnosis of drug hypersensitivity. Allergy 2002; 57: 45-51.
38. Aberer W, Bircher A, Romano A, Blanca M, Campi P, Fernandez J, Brockow K, Pichler WJ, Demoly P; ENDA Group: Drug provocation testing in the diagnosis of drug hypersensitivity reactions: general considerations. Allergy 2003; 58: 854-863.
39. Anne S, Middleton E, Reisman RE: Vancomycin anaphylaxis and successful desensitization. Ann Allergy 1994; 73: 402-404.
40. Lin RY: Desensitization in the management of vancomycin hypersensitivity. Arch Intern Med 1990; 150: 2197-2198.
41. Solensky R: Drug desensitization. Immunol Allergy Clin North Am 2004; 24: 425-443.